Your browser doesn't support javascript.
loading
Activity of aztreonam in combination with novel ß-lactamase inhibitors against metallo-ß-lactamase-producing Enterobacterales from Spain.
Vázquez-Ucha, Juan Carlos; Alonso-Garcia, Isaac; Guijarro-Sánchez, Paula; Lasarte-Monterrubio, Cristina; Álvarez-Fraga, Laura; Cendón-Esteve, Arnau; Outeda, Michelle; Maceiras, Romina; Peña-Escolano, Andrea; Martínez-Guitián, Marta; Arca-Suárez, Jorge; Bou, Germán; Beceiro, Alejandro.
Afiliación
  • Vázquez-Ucha JC; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: Juan.Carlos.Vazquez.Ucha@sergas.es.
  • Alonso-Garcia I; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Guijarro-Sánchez P; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Lasarte-Monterrubio C; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Álvarez-Fraga L; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Cendón-Esteve A; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Outeda M; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Maceiras R; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Peña-Escolano A; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain.
  • Martínez-Guitián M; NANOBIOFAR, Centre for Research in Molecular Medicine and Chronic Diseases, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, University of A Coruña, A Coruña, Spain.
  • Arca-Suárez J; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Bou G; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Beceiro A; Microbiology Department, University Hospital A Coruña, Institute of Biomedical Research of A Coruña, A Coruña, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Int J Antimicrob Agents ; 61(4): 106738, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36736925
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aztreonam / Inhibidores de beta-Lactamasas Tipo de estudio: Clinical_trials País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aztreonam / Inhibidores de beta-Lactamasas Tipo de estudio: Clinical_trials País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos